Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
Telix Pharmaceuticals (ASX: TLX, NASDAQ: TLX) has signed a strategic agreement to merge with ITM Isotope Technologies Munich SE, a global leader in therapeutic radioisotope production. The merger enhances Telix's vertical integration by combining ITM's profitable, commercial-scale isotope manufacturing and an extensive therapeutic pipeline includin…